In-Vitro Diagnostic (IVD) has emerged as the latest disruption in the dynamic landscape of healthcare market. The constant innovations of new tools and technologies in the IVD sector is driven by the molecular advances in the research and demand for better healthcare system. The rising trend of IVD stems from the fact that the aging population is increasing in number and with it the cases of chronic diseases such as cardiovascular disease, cancer and neurological disease. Hence, due to healthcare costs related to these conditions, there is an eminent need of more affordable, more informative, more accurate, faster and less invasive tools for clinical decision-making.